Korro Bio, Inc.
NASDAQ: KRRO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ram Aiyar
- Employees
- 112
- Headquarters
- Cambridge, United States
- IPO year
- 2019
- Market cap
- $137.1M
- Website
- https://www.korrobio.com
Loading KRRO…
Loading profile data…Frequently asked questions about KRRO
What does Korro Bio, Inc. (KRRO) do?
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Where does KRRO trade?
Korro Bio, Inc. (KRRO) trades on the NASDAQ Capital Market.
What sector is KRRO in?
Korro Bio, Inc. (KRRO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Korro Bio, Inc.?
Ram Aiyar is the chief executive officer of Korro Bio, Inc. (KRRO).
Where is Korro Bio, Inc. headquartered?
Korro Bio, Inc. is headquartered in United States.
Does KRRO pay a dividend?
Korro Bio, Inc. (KRRO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KRRO go public?
Korro Bio, Inc. (KRRO) completed its initial public offering in 2019.